OTUD6A and prostate carcinoma: In addition, immunohistochemical analysis showed that OTUD6A protein was also specifically highly expressed in prostate cancer tissues, which was closely associated with higher prostate specific antigen (PSA), Gleason scores, and tumor stage in patients, as well as being a predictor of higher risk of postoperative recurrence and poorer survival [84,85].